A recent court ruling limits the distribution of mifepristone, impacting medication abortion access in the US.
A US court has restricted mail-order access to the abortion pill mifepristone, affecting the most common method of medication abortion in the country. The ruling was issued within the past six hours. [source]
The drug’s manufacturer has asked the Supreme Court to intervene, arguing that the decision will cause “irreparable harm.” The company seeks a pause on the ruling while the legal process continues. [source]
Advertisement300 × 250#ad-article-middle
‘Irreparable harm’ – Drug manufacturer on the court ruling
Sources
- https://www.bbc.com/news/articles/c2k20z5yj3wo?at_medium=RSS&at_campaign=rss — Details on the court ruling and the manufacturer’s response.